Picture shows the Neuro Gamma device utilised in the study
|
|
The article "Parkinson's: Let There Be Light" written by Suvi Mahohen, was recently featured in The Australian. Mahohen speaks of the remarkable results from multiple case studies conducted by Dr Ann Liebert from the Australasian Research Institute Sydney, researching the effects of Infrared Light Therapy on Parkinson's patients. One female patient, in particular, was mentioned who suffers from Parkinson's most common symptoms: resting tremor, uncertain gait, nightmares and what bothers her most, loss of smell, which prevents her from smelling her beloved roses. She was one of 12 placed in a study which included using infrared light therapy to the abdomen three times a week for 12 weeks. This study hoped to discover whether influencing the microbiomes in the gut correlated to a positive effect on the brain. The case study's results were promising when it was discovered that the six patients put through similar protocol all had an increase of up to 20% in favourable gut-microbiome. Several statements from the participants revealed that "the trial gave [them] the ability to sleep again", balance and coordination improved and many, including the previously mentioned patient, stating that their "sense of smell improved significantly" which allowed for her to enjoy the scent of her roses once again. The future of infrared light therapy is bright with Dr Liebert planning additional studies for 2020 to further explore the full potential and capabilities of this technology. Although it can not be stated that this form of therapy will work for all Parkinson's patients, we do know that those who participated in the study can confirm that regular use of infrared light therapy has helped them reduce their symptoms and regain their natural abilities.
Dr Ann Liebert also spoke about this topic on 2SER radio, talking in depth about "How red and infrared light therapy slows parkinson's progress". To listen to her interview, click here.
|
Neuro Gamma Transcranial Device
The Vielight Neuro Gamma was utilised in this Parkinson's research. The Neuro Gamma is the next generation in transcranial-intranasal near infrared (NIR) engineering, developed specifically for regular use at home, so it can be easily operated from the comfort and convenience of a patient’s home. The Neuro Gamma uses the 40 Hz pulse rate which influences memory and cognition enhancement. Read more on our website about the published research and several ongoing trials using the Neuro Gamma device which are making it a favourable drug-free alternative that may improve symptoms associated with neurodegenerative diseases such as Parkinson's and Alzheimer’s Disease.
|
|
|
